TrialLeukemia2025

Prediction of resistance to hydroxyurea therapy in patients with polycythemia vera: a machine learning study (PV-AIM) validated in a prospective interventional phase IV trial (HU-F-AIM).

Florian H Heidel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.